I am currently partnered with an innovative biotech company advancing therapies in hematologic malignancies.
As we prepare to initiate a integral Phase 3 pivotal study inmyelofibrosis, we are seeking an experiencedMedical Directoron a contract basis to provide strategic medical leadership and clinical oversight throughout this critical development phase.Position SummaryThe Medical Director will play a key role in the planning, execution, and medical oversight of the Phase 3 trial.
This position requires expertise in hematology, ideally with direct experience in myelofibrosis or related myeloproliferative neoplasms.
The successful candidate will work cross-functionally with clinical operations, regulatory, pharmacovigilance, and external partners to ensure the trial's success.Key ResponsibilitiesProvide medical and scientific leadership for the design, execution, and reporting of the Phase 3 myelofibrosis trial.Serve as the primary medical contact for internal teams, investigators, and external stakeholders.Oversee patient safety and ensure compliance with ICH-GCP, FDA, and EMA regulations.Support clinical data analysis, review, and interpretation; contribute to regulatory submissions and clinical study reports.Engage with key opinion leaders (KOLs) in hematology to inform trial strategy and execution.Collaborate with the CRO and site investigators to ensure high-quality data collection and protocol adherence.QualificationsMD or equivalent with board certification in hematology or oncology preferred.Significant experience (10 years) in clinical development, with a strong focus on late-stage trials in hematology.Prior involvement in Phase 3 studies; experience inmyelofibrosisormyeloproliferative neoplasmsis highly desirable.Proven ability to manage cross-functional clinical teams and interact effectively with CROs and regulators.Strong analytical, strategic thinking, and communication skills.
#J-*****-Ljbffr